Reply to “Letter responding to performance of updated Enterobacterales piperacillin-tazobactam breakpoints on the MicroScan antimicrobial susceptibility testing system”

Journal of Clinical Microbiology, Ahead of Print.

https://journals.asm.org/doi/abs/10.1128/jcm.00691-23?af=R

Source: Journal of Clinical Microbiology - October 12, 2023 Category: Microbiology Authors: Romney M. HumphriesApril N. AbbottKevin AlbyJennifer Dien BardAmanda T. HarringtonAmy J. MathersPatricia J. Simner1Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA2Laboratory Medicine, D Source Type: research

More News: Allergy & Immunology | Microbiology | Pathology